Nanosystems as modulators of intestinal dapsone and clofazimine delivery.

[1]  B. Sarmento,et al.  Development of PLGA nanoparticles loaded with clofazimine for oral delivery: Assessment of formulation variables and intestinal permeability , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  B. Sarmento,et al.  pH-sensitive nanoparticles for improved oral delivery of dapsone: risk assessment, design, optimization and characterization. , 2017, Nanomedicine.

[3]  N. Durán,et al.  Nanopharmaceuticals as a solution to neglected diseases: Is it possible? , 2017, Acta tropica.

[4]  B. Sarmento,et al.  Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells , 2016, International journal of nanomedicine.

[5]  L. Abel,et al.  Pauci- and Multibacillary Leprosy: Two Distinct, Genetically Neglected Diseases , 2016, PLoS neglected tropical diseases.

[6]  S. Reis,et al.  Temperature-responsive polymeric nanospheres containing methotrexate and gold nanoparticles: A multi-drug system for theranostic in rheumatoid arthritis. , 2015, Colloids and surfaces. B, Biointerfaces.

[7]  C. Franco-Paredes,et al.  Leprosy in the 21st Century , 2015, Clinical Microbiology Reviews.

[8]  B. Sarmento,et al.  Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies. , 2013, International journal of pharmaceutics.

[9]  N. Ebel,et al.  In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles. , 2012, International journal of pharmaceutics.

[10]  R. Bhat,et al.  Leprosy: An Overview of Pathophysiology , 2012, Interdisciplinary perspectives on infectious diseases.

[11]  P. Prasad,et al.  LEPROSY THERAPY, PAST AND PRESENT: CAN WE HOPE TO ELIMINATE IT? , 2010, Indian journal of dermatology.

[12]  Y. Schneider,et al.  Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  F. Ahmad,et al.  Microemulsions: a novel approach to enhanced drug delivery. , 2008, Recent patents on drug delivery & formulation.

[14]  P. Sharma,et al.  Risk management and statistical multivariate analysis approach for design and optimization of satranidazole nanoparticles , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  A. Grzybowski,et al.  Leprosy: a glossary. , 2015, Clinics in dermatology.

[16]  V. Valluri,et al.  Immunology of leprosy and diagnostic challenges. , 2015, Clinics in dermatology.